Search

everythinglearnresearchcommunity

for

Search:↓

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Zinc is vital for immune health, growth, and preventing diarrhea.

Many COVID-19 survivors experience long-lasting symptoms, including hair loss and psychological issues.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Astaxanthin may reduce inflammation in women with PCOS, but doesn't significantly improve symptoms.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Orthodontic appliances can cause hair loss due to pressure.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Hair loss can occur after oral surgery, likely due to stress and pressure on the scalp, and usually gets better on its own.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

AB+ blood group is more common in alopecia areata patients.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Stem cell-derived conditioned medium is effective in improving hair density and thickness for alopecia treatment.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

A thorough skin history and full examination are important for diagnosing and understanding the impact of skin diseases.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Many women using contraception in Mukalla, Yemen, experience side effects like hair loss and mood swings, needing personalized care.

Exosomes from stem cells can help regrow hair better than minoxidil.

Biotin can help improve hair condition and reduce hair loss.

Microneedling therapy leads to better treatment adherence than drug therapy for hair loss.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.